For the first time, the Centers for Disease Control and Prevention is recommending adults as young as 50 get vaccinated against pneumococcal pneumonia. The recommendation is a 15-year drop from the ...
The Food and Drug Administration on Monday approved Merck’s new pneumococcal vaccine for adults 18 and older. The vaccine, which will be sold under the name Capvaxive, is designed to protect against ...
Pneumococcal infections can be very serious – they include pneumonia, meningitis, and bacteremia (a blood infection), as well ...
Are you at least 50 years old? The Center for Disease Control (CDC) now recommends you get vaccinated against pneumococcal diseases, a type of bacterial disease that can cause multiple illnesses. The ...
In October, the CDC lowered the age recommendation for the vaccine against pneumonia. Before, it was 65 and older. The health agency now says you should get the shot at age 50. KERA’s Sam Baker talks ...
The FDA approved a 21-valent pneumococcal conjugate vaccine (Capvaxive) for preventing invasive pneumococcal disease and pneumococcal pneumonia in adults, Merck announced on Monday. Specifically ...
Compared with no dexamethasone treatment, early administration of dexamethasone in children with pneumococcal meningitis lowered 30-day all-cause mortality by 50%, a new study showed. Overall ...